Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Current Oncology Reports
|
February 28, 2023
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Grace Guzman, Megan R Reed, Kevin Bielamowicz, et al.
Trends in Molecular Medicine
|
August 24, 2024
Role of NEK2 in tumorigenesis and tumor progression
Jiliang Xia, Hongyan Zhao, Jacob L Edmondson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Histone Modifications as Biomarkers for Immunotherapy
Erin M Taylor, Brian Koss, Lauren E Davis, et al.
Molecular and Cellular Biology
|
April 14, 2010
Ubiquitin-independent degradation of antiapoptotic MCL-1
Daniel P Stewart, Brian Koss, Madhavi Bathina, et al.
Cells
|
March 11, 2023
CRISPR/dCas9-KRAB-Mediated Suppression of <i>S100b</i> Restores p53-Mediated Apoptosis in Melanoma Cells
Samrat Roy Choudhury, Billie Heflin, Erin Taylor, et al.
Cancer Science
|
January 16, 2024
Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia
Brendan Frett, Kimberly E Stephens, Brian Koss, et al.
Blood
|
July 25, 2013
Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia
Brian Koss, Jeffrey Morrison, Rhonda M Perciavalle, et al.
Medicines (Basel, Switzerland)
|
June 30, 2019
Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth
Tung-Chin Chiang, Brian Koss, L Joseph Su, et al.
Molecular Immunology
|
October 14, 2023
Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma
Lauren C Morehead, Brian Koss, Daniel Fil, et al.
Genes & Development
|
June 22, 2013
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Xi Wang, Madhavi Bathina, John Lynch, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Current Oncology Reports
|
February 28, 2023
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Grace Guzman, Megan R Reed, Kevin Bielamowicz, et al.
Trends in Molecular Medicine
|
August 24, 2024
Role of NEK2 in tumorigenesis and tumor progression
Jiliang Xia, Hongyan Zhao, Jacob L Edmondson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Histone Modifications as Biomarkers for Immunotherapy
Erin M Taylor, Brian Koss, Lauren E Davis, et al.
Molecular and Cellular Biology
|
April 14, 2010
Ubiquitin-independent degradation of antiapoptotic MCL-1
Daniel P Stewart, Brian Koss, Madhavi Bathina, et al.
Cells
|
March 11, 2023
CRISPR/dCas9-KRAB-Mediated Suppression of <i>S100b</i> Restores p53-Mediated Apoptosis in Melanoma Cells
Samrat Roy Choudhury, Billie Heflin, Erin Taylor, et al.
Cancer Science
|
January 16, 2024
Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia
Brendan Frett, Kimberly E Stephens, Brian Koss, et al.
Blood
|
July 25, 2013
Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia
Brian Koss, Jeffrey Morrison, Rhonda M Perciavalle, et al.
Medicines (Basel, Switzerland)
|
June 30, 2019
Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth
Tung-Chin Chiang, Brian Koss, L Joseph Su, et al.
Molecular Immunology
|
October 14, 2023
Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma
Lauren C Morehead, Brian Koss, Daniel Fil, et al.
Genes & Development
|
June 22, 2013
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Xi Wang, Madhavi Bathina, John Lynch, et al.
Page
of 3